News
The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...
Jason DeFord, also known as Jelly Roll, has inspired fans with his genre-bending music across country, rap and rock. His ...
Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...
Scientists have uncovered a way to promote weight loss and improve blood sugar control without the unpleasant side effects of ...
A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...
By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Weight-loss drugs are expected to pull in more than $150 billion in industry-wide revenue by the early 2030s, thanks to the ...
Drugmaker Eli Lilly says after successful results in a phase 3 clinical trial, it expects to submit a GLP-1 weight loss pill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results